BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210206
DTEND;VALUE=DATE:20210207
DTSTAMP:20200212T000700Z
CREATED:20200212T000357Z
LAST-MODIFIED:20200212T000700Z
UID:39317-1612569600-1612655999@globalbiodefense.com
SUMMARY:Application Deadline: Expanding Existing Research Grants\, CRADAs for Novel Coronavirus Response
DESCRIPTION:A Notice of Special Interest (NOSI) was issued on Feb. 6\, 2020 to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV) jointly by National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of General Medical Sciences (NIGMS). \nApplications will be accepted on a rolling basis from February 6\, 2020 through February 6\, 2021 by 5:00 PM local time of the applicant organization. This NOSI expires on February 6\, 2021. An application submitted in response to this NOSI that is received on February 6\, 2021 or later\, will be withdrawn. \nRead more about this opportunity in Funding News \n  \n## \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/application-deadline-expanding-existing-research-grants-cradas-for-novel-coronavirus-response/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200702
DTEND;VALUE=DATE:20200703
DTSTAMP:20200211T231336Z
CREATED:20200211T230408Z
LAST-MODIFIED:20200211T231336Z
UID:39295-1593648000-1593734399@globalbiodefense.com
SUMMARY:Deadline for NIBIB Technology Accelerator Challenge: Handheld Diagnostics
DESCRIPTION:NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health \nThis challenge seeks designs for non-invasive technology platforms to diagnose sickle cell disease\, malaria\, and anemia. While not constrained to any specific technology\, the inspiration for this challenge comes from the widespread availability of mobile phones and the potential for mobile phone-linked sensor technologies to non-invasively detect changes in the blood and vasculature associated with these treatable diseases. \nKey Dates\nRelease Date: January 31\, 2020\nEstimated Competition Opening Date: March 2\, 2020\nEstimated Competition Closing Date: July 2\, 2020 \nRead more about this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-nibib-technology-accelerator-challenge-handheld-diagnostics/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200424
DTEND;VALUE=DATE:20200425
DTSTAMP:20200222T220028Z
CREATED:20200222T215710Z
LAST-MODIFIED:20200222T220028Z
UID:40125-1587686400-1587772799@globalbiodefense.com
SUMMARY:Quickfire Challenge Applications Due: JLABS Pediatric Influenza Innovations
DESCRIPTION:Innovators within the fields of pediatric oncology\, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150\,000 in grant funding; one year of residency at JLABS @ Washington\, DC with the use of a bench\, workstation\, and access to the JLABS @ Washington\, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies. \nThe submission deadline is 24 April 2020. Please visit the JLABS website for more information.
URL:https://globalbiodefense.com/event/quickfire-challenge-applications-due-jlabs-pediatric-influenza-innovations/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T235015Z
CREATED:20200211T234714Z
LAST-MODIFIED:20200211T235015Z
UID:39309-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Advanced Development of Diagnostics for Biothreats and EID
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases\n\nSupports advancing the development of novel\, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness.\nNumber of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up to $2 million for the non-severable base work across all contracts (direct and indirect costs combined).\nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time\n\nLearn more about this BAA in Funding News. \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T234620Z
CREATED:20200211T234423Z
LAST-MODIFIED:20200211T234620Z
UID:39307-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases\nSupports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not limited to Burkholderia spp.\, Pseudomonas aeruginosa\, Francisella tularensis\, Yersinia pestis\, and E. coli\, and 2) for emerging viruses and pandemic preparedness that includes but is not limited to alphaviruses (e.g.\, Eastern Equine Encephalitis) and bunyaviruses (e.g.\, Rift Valley Fever Virus). \nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time \nLearn more about this opportunity in here. \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-advanced-development-of-vaccine-candidates-for-biodefense-and-emerging-infectious-diseases/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T233920Z
CREATED:20200211T233539Z
LAST-MODIFIED:20200211T233920Z
UID:39302-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Therapeutic Products for Biodefense\, AMR Infections\, and Emerging Infectious Diseases
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 004: Development of Therapeutic Products for Biodefense\, Anti-Microbial Resistant (AMR) Infections\, and Emerging Infectious Diseases\nSupports development of promising new therapeutics to address infections caused by NIAID Category A\, B\, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 \, including optimization\, preclinical (investigational new drug-enabling)\, and clinical trials that include Phase I and Phase II studies. \nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time \nRead more on this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-therapeutic-products-for-biodefense-amr-infections-and-emerging-infectious-diseases/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200409
DTEND;VALUE=DATE:20200410
DTSTAMP:20200211T233435Z
CREATED:20200211T233017Z
LAST-MODIFIED:20200211T233435Z
UID:39300-1586390400-1586476799@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Development of Radiation/Nuclear Medical Countermeasures
DESCRIPTION:Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1\nThis research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. \nIt supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation from a radiological or nuclear incident\, thereby leading to a reduction in radiation-associated morbidities and mortalities. \nDue Date: April 9\, 2020\, by 3 p.m. Eastern Time \nRead more about this opportunity in Funding News.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-development-of-radiation-nuclear-medical-countermeasures/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200406
DTEND;VALUE=DATE:20200407
DTSTAMP:20200211T235602Z
CREATED:20200211T235220Z
LAST-MODIFIED:20200211T235602Z
UID:39312-1586131200-1586217599@globalbiodefense.com
SUMMARY:Proposals Due: Influenza Data Processing and Outreach
DESCRIPTION:If your small business has strong experience with scientific data processing and outreach\, consider sending a contract proposal to establish an Influenza Data Processing and Communication Center (iDPCC). \nThis solicitation recompetes and renames the current influenza DPCC contract to support NIAID’s Centers of Excellence for Influenza Research and Response (CEIRR) network. \nSubmit your proposal by April 6\, 2020. If you have any questions\, send them to the contracting officer listed in the solicitation no later than March 4\, 2020. \nLearn more about this funding opportunity in Funding News \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status. \n 
URL:https://globalbiodefense.com/event/proposals-due-influenza-data-processing-and-outreach/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200228
DTEND;VALUE=DATE:20200229
DTSTAMP:20200211T234244Z
CREATED:20200211T234042Z
LAST-MODIFIED:20200211T234244Z
UID:39305-1582848000-1582934399@globalbiodefense.com
SUMMARY:Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68
DESCRIPTION:HHS-NIH-NIAID-BAA2020-1\nResearch Area 002: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68\nSupports the development of inactivated Enterovirus D68 vaccines\, preferably using adjuvants that minimize regulatory concerns and expedite vaccine development into a Phase I clinical trial. \nDue Date: February 28\, 2020\, by 3 p.m. Eastern Time \n  \nLearn more about this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-niaid-baa-proposals-advanced-development-of-vaccine-candidates-for-acute-flaccid-myelitis-afm-associated-with-enterovirus-d68/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200220
DTEND;VALUE=DATE:20200221
DTSTAMP:20200212T001500Z
CREATED:20200212T001251Z
LAST-MODIFIED:20200212T001500Z
UID:39322-1582156800-1582243199@globalbiodefense.com
SUMMARY:DARPA BTO BAA Deadline: Personalized Protective Biosystems
DESCRIPTION:The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator\, provide operational flexibility\, extend mission duration\, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing a second layer of protection\, at the tissue barrier\, with bio-molecular\, commensal organisms\, or other technologies that protect the skin\, eyes\, and airway from CB threats. PPB will improve mission execution by solving the current protective equipment limitations including threat-specific vulnerabilities\, thermal/logistical burdens\, exposure risks during equipment removal/decontamination\, and on-demand availability during unexpected threat situations. \nA Proposer’s Day was held on 4 Dec 2019 for potential performers. Attendance at the event is not a prerequisite to submit a response to the DARPA Personalized Protective Biosystem Broad Agency Announcement (BAA). The full proposal deadline for this BAA is 20 February 2020. \nLearn more about this opportunity in Funding News. \n  \n## \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/darpa-bto-baa-deadline-personalized-protective-biosystems/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200214
DTEND;VALUE=DATE:20200215
DTSTAMP:20200212T001055Z
CREATED:20200204T000815Z
LAST-MODIFIED:20200212T001055Z
UID:39319-1581638400-1581724799@globalbiodefense.com
SUMMARY:Deadline: CEPI Call for Proposals - Vaccines Against Novel Coronavirus
DESCRIPTION:CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. \nThe call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations\, for-profit companies\, international organisations and foundations\, joint R&D ventures\, government research organisations\, and academic institutions ideally having a geographical footprint internationally. \nLearn more in funding news. \nThe deadline for applications is Friday 14 Feb (2020)\, 15:00 CET. \n  \n## \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-cepi-call-for-proposals-vaccines-against-novel-coronavirus/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200131
DTEND;VALUE=DATE:20200201
DTSTAMP:20200116T175238Z
CREATED:20200116T173601Z
LAST-MODIFIED:20200116T175238Z
UID:37406-1580428800-1580515199@globalbiodefense.com
SUMMARY:Registration Deadline: MCMs for Acute and Chronic Effects of Ocular Chemical Toxicity
DESCRIPTION:Meeting registration will close on January 31\, 2020 for the U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity. \nThe meeting will be held Feb 25-26\, 2020 at the NIAID Conference Center in Rockville\, Md. \nThe meeting is sponsored by the Chemical Countermeasures Research Program (CCRP)\, a component of the broader civilian biodefense research effort within HHS and NIH. \nLearn More
URL:https://globalbiodefense.com/event/registration-deadline-mcms-for-acute-and-chronic-effects-of-ocular-chemical-toxicity/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200117
DTEND;VALUE=DATE:20200118
DTSTAMP:20200116T172303Z
CREATED:20200101T171718Z
LAST-MODIFIED:20200116T172303Z
UID:37403-1579219200-1579305599@globalbiodefense.com
SUMMARY:Public Comments Due: Tick-Borne Disease Working Group
DESCRIPTION:The public will have an opportunity to present their views to the Tick-Borne Disease Working Group Meeting on Jan 28-29. \n\n\n\nVerbal comments (in-person): \n\nRequests to provide verbal public comment must be submitted via email by midnight Tuesday\, January 17\, 2020\, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Verbal Public Comment – January 28-29 Meeting. In addition\, please indicate if you will be providing verbal comment in person or by phone. If by phone\, you will be provided a call-in number and and time to call.\nA total of 30 minutes has been set aside for verbal comments on both days. Each person will be limited to 3 minutes in order to accommodate as many speakers as possible. If more requests are received than can be accommodated\, speakers will be randomly selected.\nYour remarks will be heard over a live webcast and will become part of the archived recording and meeting summary that will be posted on this website.\n\nWritten comments \n\nWritten public comments must be submitted via email by midnight Tuesday\, January 17\, 2020\, ET to tickbornedisease@hhs.gov. In the Subject line please enter: Written Public Comment – January 28-29 Meeting.\nWhen you submit your written comment\, please include a statement letting the TBDWG know how you would like to be identified with your comment. You may choose to use your name or to be anonymous. You may also list your city and/or state. If you are providing comments on behalf of an organization\, please include the name of the organization. TBDWG cannot post your comment until you let us know how you would like to be identified.\nComments should either be provided in the body of your email\, or in an attachment in Word format and equivalent to no more than 4 pages in Calibri or Times New Roman\, 11 point font. Text that exceeds the 4 pages will be deleted.\nTBDWG will not post graphics\, images\, text boxes\, or tables. If included with your comment\, they will not be able to retain them.\nTBDWG can only create hyperlinks to “.gov” sites (local\, state\, or federal). For all other reference sites\, please insert the full URL (e.g.\, http://learn.genetics.utah.edu/content/epigenetics).\nTBDWG is also unable to include attachments as supporting documentation to your written comments.
URL:https://globalbiodefense.com/event/public-comments-due-tick-borne-disease-working-group/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200116
DTEND;VALUE=DATE:20200117
DTSTAMP:20200115T041526Z
CREATED:20191220T154354Z
LAST-MODIFIED:20200115T041526Z
UID:35673-1579132800-1579219199@globalbiodefense.com
SUMMARY:Call for Abstracts Deadline: NACCHO 360
DESCRIPTION:The National Association for County and City Health Officials (NACCHO) will host NACCHO 360 July 7–9\, 2020\, in Denver\, Colorado. This innovative convening aims to break down silos by connecting the traditional NACCHO annual conference with PHIITS (Public Health Informatics\, Information Technology\, and Surveillance)\, a re-imagined Public Health Informatics conference that goes beyond informatics to explore local health department information technology infrastructure and public health surveillance. Abstracts must be submitted by January 16 at 11:59 pm (EST). \nTopics areas of interest highlighted by the Global Biodefense staff include: \n\nDisease transmission\, patterns\, and trends in the era of global travel and mass transit\nThe rise of misinformation and disinformation\nEducating policy makers on public health issues\nDisaster preparedness planning\nInformation systems and use of health information technology to improve population\nhealth\nUse of data analytics\, including big data to understand population health\nGovernance\, including laws\, policies\, and standards that affect information exchange\nInnovations and novel applications of information and technology – including tools for\nanalysis and visualization (e.g.\, R\, GIS\, Python\, SAS\, Tableau) – to create solutions that\naddress pressing public health challenges\nDelivering accurate\, accessible\, and actionable health information that is targeted and tailored\nActivities to facilitate the meaningful use of health IT and the exchange of health information among public health professionals\, healthcare\, and other stakeholders\nChallenges and logistics of implementing telehealth\nInteroperability of technology systems in the 21st century\nCapacity-building for community leaders to educate policymakers and promote legislative change\n\nPlease visit the NACCHO 360 Abstracts page for more information.
URL:https://globalbiodefense.com/event/call-for-abstracts-deadline-naccho-360/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200110
DTEND;VALUE=DATE:20200111
DTSTAMP:20191220T164612Z
CREATED:20191220T153010Z
LAST-MODIFIED:20191220T164612Z
UID:35670-1578614400-1578700799@globalbiodefense.com
SUMMARY:Call for Abstracts Deadline: 2020 CSTE Annual Conference
DESCRIPTION:The Council of State and Territorial Epidemiologists (CSTE) will host their CSTE Annual Conference 2020 on June 28–July 2\, 2020\, in Seattle\, Washington. Abstracts must be submitted by January 10 at 11:59 pm (EST). Abstract submission topics include chronic disease/maternal and child health/oral health\, cross cutting\, environmental health\, infectious disease\, injury\, occupational health\, substance use\, and surveillance/informatics. \nHighlighted topics of interest include: \n\nBorder and International Health\nCommunicating Epidemiology\nData Sharing\nEpidemiologic Methods\nEpidemiology Capacity and Workforce Development\nLocal Epidemiology and Sub‐County Estimation\nPublic Health Emergency Preparedness and Response\nTribal Epidemiology\nEnvironmental Health\nAir Quality & Respiratory Health\nDisaster Epidemiology\nEnvironmental Health Investigations\nAntimicrobial Resistance\nEmerging & Miscellaneous Infectious Diseases\nHealthcare‐Associated Infections\nHepatitis\nHIV & STD\nInfluenza & Other Respiratory Diseases (including TB)\nVaccine‐Preventable Diseases\nVector‐Borne & Zoonotic Diseases\nAntimicrobial resistance surveillance\nDisease‐specific surveillance and informatics applications\nElectronic disease surveillance systems (e.g.\, EDSS\, NEDSS\, etc.)\nLeveraging external infrastructure to improve public health surveillance (e.g.\, EHRs\, HIEs).\nNovel and emerging surveillance methods\, analytics\, and data management\n\nStudents are encouraged to submit abstracts for sessions offered at the CSTE annual conference. To be eligible for consideration\, abstracts must be authored by students currently enrolled full time in an undergraduate or graduate program who are actively pursuing a degree in public health or related field. Discounted registration fees are offered to qualified students. \nPlease visit the CTSE Call for Abstracts page for more information.
URL:https://globalbiodefense.com/event/call-for-abstracts-deadline-2020-cste-annual-conference/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191202
DTEND;VALUE=DATE:20191203
DTSTAMP:20191117T030018Z
CREATED:20191117T025609Z
LAST-MODIFIED:20191117T030018Z
UID:34100-1575244800-1575331199@globalbiodefense.com
SUMMARY:DIGET Proposers Day Lightning Talk Presentation Submission Deadline
DESCRIPTION:Requests for lightning talks and sidebar meetings will be accepted on\na first-come basis. All presentations must be emailed to DARPA-SN-20-12@darpa.mil\nno later than 12:00 PM ET on December 2\, 2019. Specific content\, communications\, networking\,\nand team formation are the sole responsibility of the participants. \nLearn more about this event and the requirements: DARPA DIGET Proposers Day – Detect It with Gene Editing Technologies Program \nGlobal Biodefense is a news publication and not directly responsible for this event. Information is subject to change. Please contact the event organizers for the most up-to-date information.
URL:https://globalbiodefense.com/event/diget-proposers-day-lightning-talk-presentation-submission-deadline/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191022
DTEND;VALUE=DATE:20191023
DTSTAMP:20190907T222955Z
CREATED:20190907T222920Z
LAST-MODIFIED:20190907T222955Z
UID:30280-1571702400-1571788799@globalbiodefense.com
SUMMARY:ASM Agar Art Contest Submission Deadline
DESCRIPTION:ASM’s 5th Agar Art Contest celebrates the beautiful and diverse world of microbes. Submit your bioart masterpiece no later than October 22\, 2019. \n \nThere are different competition categories for professionals\, amateur enthusiasts and for kids (with adult supervision). Pieces must be created safely in the appropriate Bio Safety Level environment for the organisms used. For more information\, please consult ASM’s Guidelines for Biosafety in Teaching Laboratories. \nLearn more
URL:https://globalbiodefense.com/event/asm-agar-art-contest/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190913
DTEND;VALUE=DATE:20190914
DTSTAMP:20190904T174022Z
CREATED:20190821T041439Z
LAST-MODIFIED:20190904T174022Z
UID:30062-1568332800-1568419199@globalbiodefense.com
SUMMARY:Lightning Talks Application Deadline - BARDA Industry Day Presentations
DESCRIPTION:Submit your application to participate in the BARDA Industry Day 2019 Lightning Talks on 16 Oct 2019. \nLightning Talks are intentionally designed to be brief\, energetic\, and full of information to pique the curiosity of industry and government colleagues and prospective partners. If you are interested in submitting a topic to present on behalf of yourself or your company\, please enter your information as requested and provide a brief (maximum 500 word) summary of your proposed presentation\, with optional 1 slide. \nApplications will be evaluated on the following criteria: \n\nRelevance to ASPR\, BARDA \, and DRIVe mission\nRelevance to BARDA Industry Day 2019 theme\, “Catalyzing Health Security”\nGoals of proposed talk: Are you seeking partnerships/collaborations? Accelerating product development? Looking for new applications for existing technologies?\n\nApplications must be received by 11:59 PM ET Friday\, September 13\, 2019. BARDA will notify those that have been accepted for Lightning Talks the week of September 22\, 2019. \nSubmit Your Application to Present Here: Lightning Talks Submission Form
URL:https://globalbiodefense.com/event/lightning-talk-application-deadline-barda-industry-day-presentations/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190909
DTEND;VALUE=DATE:20190910
DTSTAMP:20190812T140040Z
CREATED:20190812T140040Z
LAST-MODIFIED:20190812T140040Z
UID:29961-1567987200-1568073599@globalbiodefense.com
SUMMARY:Comments Due:  2019 Draft Guidelines for the Prevention\, Diagnosis\, and Treatment of Lyme Disease
DESCRIPTION:The Infectious Diseases Society of America (IDSA)\, American Academy of Neurology (AAN)\, and American College of Rheumatology (ACR) are now accepting comments on the “2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease.” Feedback is sought not only from physicians and healthcare professionals\, but also individuals affected by Lyme disease\, such as patients\, care givers\, patient organization members\, advocates\, and researchers. The deadline for submitting comments has been extended until Sept. 9\, 2019. \nTo view the draft guidelines\, supplementary materials\, and submit comments\, please see below. \n2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease \n2019 Draft Supplement Materials for the Prevention\, Diagnosis and Treatment of Lyme Disease \nPublic comments are due by 5PM Eastern on 9 September 2019.
URL:https://globalbiodefense.com/event/comments-due-2019-draft-guidelines-for-the-prevention-diagnosis-and-treatment-of-lyme-disease/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190719
DTEND;VALUE=DATE:20190720
DTSTAMP:20190421T174235Z
CREATED:20190421T172854Z
LAST-MODIFIED:20190421T174235Z
UID:26391-1563494400-1563580799@globalbiodefense.com
SUMMARY:Proposals Due: RNCP-Wide Dosimetry Guidance and Monitoring of Sources and Irradiation Protocols
DESCRIPTION:NIAID is soliciting proposals to assess the current state of radiation dosimetry within the Radiation Nuclear Countermeasures Program to develop a consistent means of comparison and reproducibility across institutes. \nConsider submitting an offer if you can provide services\, facilities\, expertise\, and capabilities needed to develop a centralized dosimetry harmonization effort. Ideally\, you will have preliminary data demonstrating consistent and accurate dosimetry exposures within a clearly defined radiation exposure system that is used for nonclinical radiation animal (and in vitro) studies in more than one animal species (e.g.\, mouse and nonhuman primate). \nRead the full article on this opportunity here.  \nResponses are due July 19\, 2019\, at 3 p.m. Eastern time.
URL:https://globalbiodefense.com/event/proposals-due-rncp-wide-dosimetry-guidance-and-monitoring-of-sources-and-irradiation-protocols/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190630
DTEND;VALUE=DATE:20190701
DTSTAMP:20190619T043333Z
CREATED:20190602T043051Z
LAST-MODIFIED:20190619T043333Z
UID:29329-1561852800-1561939199@globalbiodefense.com
SUMMARY:Estimated Release Date of Draft WHO Roadmap on Neglected Tropical Diseases 2012–2020
DESCRIPTION:At its eleventh meeting in 2018\, the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) recommended that WHO initiate a consultative process with the global NTD community to set new targets and milestones beyond 2020 to achieve the health-related 2030 United Nations Sustainable Development Goals (SDGs). \nPhase 1 feedback was collected\, summarized and presented on 29-30 April 2019 at a STAG-NTD meeting. A second round of feedback from stakeholders will take place following the late June release of the Roadmap draft with the goal of finalizing the Roadmap and milestones by 1 August. \nSource: World Health Organization
URL:https://globalbiodefense.com/event/estimated-release-date-of-draft-who-roadmap-on-neglected-tropical-diseases-2012-2020/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190627
DTSTAMP:20190620T150001Z
CREATED:20190620T150001Z
LAST-MODIFIED:20190620T150001Z
UID:29344-1561507200-1561593599@globalbiodefense.com
SUMMARY:GHSA Supplemental Funding Opportunity Application Deadline - Ebola\, Cholera Outbreak Response
DESCRIPTION:CDC’s Emergency Response and Recovery Branch may have funds available to support emergency activities in response to the Ebola outbreak in the Democratic Republic of the Congo\, the Rohingya refugee crisis in Bangladesh\, and/or global cholera outbreak response. \nIn response to the recent Ebola outbreak in West Africa\, Emergency Response and Recovery Branch (ERRB) has coordinated the establishment of CDC’s Global Rapid Response Team (GRRT). This funding opportunity supports the implementation of programs and activities targeted at increasing the rapid response capacity of CDC’s partners to support populations affected by disease outbreaks\, complex humanitarian emergencies\, armed conflict and other disasters. Its purpose is to decrease the time needed to respond to critical public health emergencies through the provision of logistical mechanisms required for the rapid public health response to humanitarian emergencies and disease outbreaks throughout the world. This effort will expand CDC’s ability to respond quickly and effectively in the event of public health emergencies worldwide. \nAfter a partner organization is initially selected for funding for a specific strategy and activity\, that partner organization may be requested to provide an application for additional strategies and activities through supplemental funding requests and/or a continuation application at the time when CDC solicits the partner organizations for a request for application for emergency funding. Requests to expand strategies and activities are not limited to particular focus areas or countries where the organization was initially selected for funding. It remains at the partner organizations’ discretion to submit an application in response to these supplemental requests or request for applications. \nRead more: Emergency Response and Recovery Supplemental Funding for GHSA Support
URL:https://globalbiodefense.com/event/ghsa-supplemental-funding-opportunity-application-deadline-ebola-cholera-outbreak-response/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190620
DTEND;VALUE=DATE:20190621
DTSTAMP:20190617T153157Z
CREATED:20190617T153157Z
LAST-MODIFIED:20190617T153157Z
UID:29307-1560988800-1561075199@globalbiodefense.com
SUMMARY:CDC RFI Deadline: Rapid Response to Outbreaks for Sample Collection
DESCRIPTION:CDC is seeking information from companies and other organizations about their capability and capacity to deploy to the site of a domestic or international outbreak or public health emergency\, obtain informed consent\, collect specimens (blood\, urine\, swabs\, etc.) from identified patients\, and safely ship these specimens to CDC in accordance with all applicable local\, state\, and federal and/or international laws\, and regulations. \nAdditionally\, the agency is seeking to obtain information\, needs\, capabilities\, constraints\, capacities\, and requirements of those vendors and companies who do have an interest (or potential interest) in providing the needed services. \nRead more: Collection of Specimens During Outbreak or Public Health Emergency
URL:https://globalbiodefense.com/event/cdc-rfi-deadline-rapid-response-to-outbreaks-for-sample-collection/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190521
DTSTAMP:20190421T201832Z
CREATED:20190421T201149Z
LAST-MODIFIED:20190421T201832Z
UID:26412-1558310400-1558396799@globalbiodefense.com
SUMMARY:RFI Deadline - Malaria Prophylactic Drug Tafenoquine
DESCRIPTION:The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick\, MD\, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. \nThe operational testing will look at the drug’s performance attributes and usability. \nThe DoD is seeking sources\, capability statements\, and industry feedback for this requirement for one commercial lot of ~120\,000 tablets (7\,500 packages) of Tafenoquine brand name Arakoda immediately\, with base Contract Line Item Number (CLIN) and three optional CLINs to procure up to 3\,750 packages per CLIN. \nEntities interested in submitting a response must furnish in writing\, a 2-3 page (not including cover page\, index or list of references) synopsis of their capability to provide the described product\, including any necessary lead time. \nResponses are due Monday\, 20 May 2019\, 3:00 PM EST. \nRead the full article on the Malaria Drug RFI here.
URL:https://globalbiodefense.com/event/rfi-deadline-malaria-prophylactic-drug-tafenoquine/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/global-biodefense-events-calendar-7.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190503
DTEND;VALUE=DATE:20190504
DTSTAMP:20190429T042725Z
CREATED:20190402T041450Z
LAST-MODIFIED:20190429T042725Z
UID:27085-1556841600-1556927999@globalbiodefense.com
SUMMARY:Eureka Prize for Infectious Diseases Research
DESCRIPTION:Entries are being accepted for the Eureka Prize for Infectious Diseases Research through 3 May 2019. \nActivity entered for this prize must have been undertaken in Australia or its territories (as defined by the Australian Government). \nFor a team entry\, the team leader must be either a) an Australian citizen\, b) an Australian permanent resident\, or c) a New Zealand citizen who was resident in Australia\, at the time the research entered was undertaken. \nSponsored by the Australian Infectious Diseases Research Centre\, the $10\,000 prize is awarded to an individual\, group or team for an outstanding recent contribution to infectious diseases research. \nActivity entered for this prize must have been undertaken as a single body of focused infectious diseases research in the past 7 years and have been published in one or more internationally respected scientific journals\, books or equivalent electronic publications. \nPlease visit the Eureka Prize for Infectious Diseases Research website for more information.
URL:https://globalbiodefense.com/event/eureka-prize-for-infectious-diseases-research/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190308
DTEND;VALUE=DATE:20190309
DTSTAMP:20240623T192421Z
CREATED:20190224T232313Z
LAST-MODIFIED:20240623T192421Z
UID:24699-1552003200-1552089599@globalbiodefense.com
SUMMARY:Call for Reports: Evidence-Based Practices for Public Health Emergency Preparedness and Response
DESCRIPTION:Committee on Evidence – Based Practices for Public Health Emergency Preparedness and Response \nThe National Academies of Sciences\, Engineering\, and Medicine s soliciting information to help inform the deliberations of a consensus study committee sponsored by the Centers for Disease Control and Prevention. \nThe committee has been charged with conducting a comprehensive review and grading of the evidence for select public health emergency preparedness and response (PHEPR) practices. The committee’s report will provide recommendations on PHEPR practices that public health agencies should or should not adopt based on the evidence and will also identify future research needs to address gaps in evidence-based PHEPR practices. \nThe committee is issuing a call for reports to help enhance its comprehensive review. \nAnyone wishing to submit reports should email the committee at preparedness@nas.edu. Materials should be submitted by Friday\, March 8\, 2019. Please note that any materials or written information shared with the committee will be placed in the committee’s Public Access File (PAF)\, and may be provided to the public upon request.
URL:https://globalbiodefense.com/event/call-for-reports-evidence-based-practices-for-public-health-emergency-preparedness-and-response/
CATEGORIES:Deadlines
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190308
DTEND;VALUE=DATE:20190309
DTSTAMP:20240623T231311Z
CREATED:20190223T200908Z
LAST-MODIFIED:20240623T231311Z
UID:23755-1552003200-1552089599@globalbiodefense.com
SUMMARY:Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance
DESCRIPTION:Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance by March 8\, 2019. \nNIAID is refining the five-year strategic framework for antibacterial resistance (AR) research and development\, Antibacterial Resistance Program: Current Status and Future Directions pdf. \nPublished in 2014\, the framework identified the following priorities: \n\nSystems Biology and Antibacterial Resistance: New Directions for Drug Discovery\nHarnessing the Immune System to Combat Bacterial Infections\nDisarm\, But Leave Unharmed: Exploring Anti-Virulence Strategies\nSynthetic Microbiota: An Ecobiological Approach\nLess Is Better: Diagnostics to Guide Use of Narrow-Spectrum Therapeutics\nExploiting Natural Predators: The Specificity of Phage Therapy\nTeaching Old Drugs New Tricks: Extending the Clinical Utility of Antibacterial Drugs\n\nNIAID seeks community feedback to inform an update of the framework. Send your comments identifying: \n\nAdditional research activities needed to help advance the above-listed strategic approaches\nAdditional strategic approaches or technologies that have the potential to transform our understanding of and ability to prevent\, diagnose\, or treat resistant bacterial infections\n\nTo submit a response\, send a PDF or MS Word document of 500 words or less to NIAIDAntibioticResistanceRFI2019@niaid.nih.gov. The deadline to reply is March 8\, 2019. Take care to avoid sharing any proprietary\, classified\, confidential\, trade secret\, or sensitive information in your response.
URL:https://globalbiodefense.com/event/niaid-research-framework-amr-deadline-2019/
CATEGORIES:Deadlines
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190128
DTEND;VALUE=DATE:20190129
DTSTAMP:20190125T013842Z
CREATED:20190125T013614Z
LAST-MODIFIED:20190125T013842Z
UID:22171-1548633600-1548719999@globalbiodefense.com
SUMMARY:Comments Due: Code of Conduct for Timely Sharing of Pathogen Genetic Sequence Data During Outbreak
DESCRIPTION:A key concern in recent outbreaks has been variable timelines between the start of an outbreak and the public availability of the first and subsequent genetic sequences. \nThe World Health Organization (WHO)\, upon consultation with many stakeholders and institutions working in the pathogen sequencing arena\, is proposing elements of a code of conduct for genetic sequencing data sharing in infectious disease outbreaks. \nThrough this code of conduct WHO seeks to enable rapid international sharing of sequence data\, allowing public health authorities\, product developers and researchers to collaborate more effectively from a position of mutual trust with respect for submitters’ rights to the information they provide. \nThe draft document is available for public comment until close of business on 28 January 2019. Comments may be submitted by individuals or organizations\, and will be considered for incorporation in WHO’s final Code of Conduct.
URL:https://globalbiodefense.com/event/comments-due-code-of-conduct-for-timely-sharing-of-pathogen-genetic-sequence-data-during-outbreak/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/genomic-sequencing-data-sharing-code-of-conduct.png
END:VEVENT
END:VCALENDAR